Susan Sutherland

1.9k total citations · 1 hit paper
16 papers, 1.1k citations indexed

About

Susan Sutherland is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Susan Sutherland has authored 16 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 7 papers in Pulmonary and Respiratory Medicine and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Susan Sutherland's work include Colorectal Cancer Treatments and Studies (5 papers), Gastric Cancer Management and Outcomes (3 papers) and Bone health and treatments (2 papers). Susan Sutherland is often cited by papers focused on Colorectal Cancer Treatments and Studies (5 papers), Gastric Cancer Management and Outcomes (3 papers) and Bone health and treatments (2 papers). Susan Sutherland collaborates with scholars based in United States, Canada and United Kingdom. Susan Sutherland's co-authors include Donna Hollis, Donna Niedzwiecki, Richard M. Goldberg, Richard L. Schilsky, Herbert I. Hurwitz, Pankaj Bhargava, Timothy F. Wozniak, Eileen M. O’Reilly, Mary F. Mulcahy and Joel Picus and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Oral and Maxillofacial Surgery and International Journal of Oral and Maxillofacial Surgery.

In The Last Decade

Susan Sutherland

15 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Gemcitabine Plus Bevacizumab Compared With Gemcitabine Plus Placebo in Patients With Advanced Pancreatic Cancer: Phase III Trial of the Cancer and Leukemia Group B (CALGB 80303)

2010 679 citations Hedy L. Kindler, Donna Niedzwiecki et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Susan Sutherland United States	9	720	362	292	227	146	16	1.1k
B. Mirtsching United States	12	1.1k 1.6×	459 1.3×	288 1.0×	182 0.8×	126 0.9×	27	1.3k
Ralph Wong Canada	5	1.3k 1.8×	400 1.1×	325 1.1×	209 0.9×	113 0.8×	8	1.5k
Nikolaos Ziras Greece	17	996 1.4×	369 1.0×	304 1.0×	150 0.7×	121 0.8×	55	1.2k
Antonio Cubillo Spain	18	864 1.2×	253 0.7×	233 0.8×	208 0.9×	100 0.7×	88	1.1k
Kanwal Raghav United States	19	568 0.8×	349 1.0×	199 0.7×	221 1.0×	160 1.1×	52	1.1k
D. Quietzsch Germany	14	886 1.2×	461 1.3×	291 1.0×	135 0.6×	67 0.5×	30	1.1k
Stacey Stein United States	18	802 1.1×	387 1.1×	327 1.1×	315 1.4×	167 1.1×	74	1.4k
Sandra J. Casak United States	18	455 0.6×	215 0.6×	107 0.4×	171 0.8×	148 1.0×	32	1.0k
Andrew Dean Australia	17	1.1k 1.5×	694 1.9×	267 0.9×	262 1.2×	169 1.2×	104	1.6k
Nathan M. Mollberg United States	16	728 1.0×	564 1.6×	308 1.1×	205 0.9×	76 0.5×	29	1.5k

Countries citing papers authored by Susan Sutherland

Since Specialization

Citations

This map shows the geographic impact of Susan Sutherland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan Sutherland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan Sutherland more than expected).

Fields of papers citing papers by Susan Sutherland

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan Sutherland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan Sutherland. The network helps show where Susan Sutherland may publish in the future.

Co-authorship network of co-authors of Susan Sutherland

This figure shows the co-authorship network connecting the top 25 collaborators of Susan Sutherland. A scholar is included among the top collaborators of Susan Sutherland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan Sutherland. Susan Sutherland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Williams, G.D., Susan Sutherland, James R. J. Haycocks, et al.. (2025). High-throughput chemical genomic screening: a step-by-step workflow from plate to phenotype. mSystems. 10(12). e0088525–e0088525.

Sutherland, Susan, et al.. (2024). Dental antimicrobial stewardship: a qualitative study of perspectives among Canadian dentistry sector leaders and experts in antimicrobial stewardship. JAC-Antimicrobial Resistance. 6(3). dlae082–dlae082. 4 indexed citations

El-Rabbany, Mohamed, Nick Blanas, Susan Sutherland, et al.. (2022). Surgical Therapy in Patients With Medication-Related Osteonecrosis of the Jaw Is Associated With Disease Resolution and Improved Quality of Life: A Prospective Cohort Study. Journal of Oral and Maxillofacial Surgery. 80(6). 1084–1093. 6 indexed citations

El-Rabbany, Mohamed, Nick Blanas, Susan Sutherland, et al.. (2021). Development and evaluation of the clinimetric properties of the Medication-Related Osteonecrosis of the Jaw Quality of Life Questionnaire (MRONJ-QoL). International Journal of Oral and Maxillofacial Surgery. 51(6). 768–775. 4 indexed citations

Sutherland, Susan & Karen Moline. (2015). The ARCTIC Workshop: An Interprofessional Education Activity in an Academic Health Sciences Center. Journal of Dental Education. 79(6). 636–643. 8 indexed citations

Demmy, Todd L., Lin Gu, Jack E. Burkhalter, et al.. (2012). Optimal Management of Malignant Pleural Effusions (Results of CALGB 30102). Journal of the National Comprehensive Cancer Network. 10(8). 975–982. 71 indexed citations

Demmy, Todd L., Lixu Gu, Jack E. Burkhalter, et al.. (2010). Comparison of in-dwelling catheters and talc pleurodesis in the management of malignant pleural effusions.. Journal of Clinical Oncology. 28(15_suppl). 9031–9031. 5 indexed citations

Kindler, Hedy L., Donna Niedzwiecki, Donna Hollis, et al.. (2010). Gemcitabine Plus Bevacizumab Compared With Gemcitabine Plus Placebo in Patients With Advanced Pancreatic Cancer: Phase III Trial of the Cancer and Leukemia Group B (CALGB 80303). Journal of Clinical Oncology. 28(22). 3617–3622. 679 indexed citations breakdown →

Venook, Alan P., Charles D. Blanke, Donna Niedzwiecki, et al.. (2007). Revisiting the Cancer and Leukemia Group B/Southwest Oncology Group 80405 Trial: A Phase III Trial of Chemotherapy and Biologic Agents for Patients with Untreated Advanced Colorectal Adenocarcinoma. Clinical Colorectal Cancer. 6(7). 536–538. 12 indexed citations

10.

Venook, Alan P., Charles D. Blanke, Richard M. Goldberg, et al.. (2006). Assessing the combination of FOLFOX or FOLFIRI with bevacizumab, cetuximab, or both in metastatic colorectal cancer. Community Oncology. 3(9). 593–598. 4 indexed citations

11.

Venook, Alan P., Donna Niedzwiecki, Donna Hollis, et al.. (2006). Phase III study of irinotecan/5FU/LV (FOLFIRI) or oxaliplatin/5FU/LV (FOLFOX) ± cetuximab for patients (pts) with untreated metastatic adenocarcinoma of the colon or rectum (MCRC): CALGB 80203 preliminary results. Journal of Clinical Oncology. 24(18_suppl). 3509–3509. 92 indexed citations

12.

Venook, Alan P., Charles D. Blanke, Donna Niedzwiecki, et al.. (2005). Cancer and Leukemia Group B/Southwest Oncology Group Trial 80405: A Phase III Trial of Chemotherapy and Biologics for Patients with Untreated Advanced Colorectal Adenocarcinoma. Clinical Colorectal Cancer. 5(4). 292–294. 23 indexed citations

13.

Sutherland, Susan. (2004). An Introduction to Systematic Reviews. Journal of Evidence Based Dental Practice. 4(1). 47–51. 16 indexed citations

14.

Sutherland, Susan. (2001). Evidence-based dentistry: Part V. Critical appraisal of the dental literature: papers about therapy.. PubMed. 67(8). 442–5. 20 indexed citations

15.

Malcolm, Robert, et al.. (1999). Carbohydrate-deficient transferrin and alcohol use in medical examiner cases. Journal of Clinical Forensic Medicine. 6(3). 169–169. 2 indexed citations

16.

Ludwicka, A, T. Ohba, Maria Trojanowska, et al.. (1995). Elevated levels of platelet derived growth factor and transforming growth factor-beta 1 in bronchoalveolar lavage fluid from patients with scleroderma.. PubMed. 22(10). 1876–83. 132 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact